AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Abstract
Diffuse alveolar damage (DAD) is the chief
pathological basis of life- threatening acute pulmonary conditions
like the acute respiratory distress syndrome (ARDS). It may be
considered as a model of lung regeneration and wound-repair,
because the natural history of ARDS may include the resolution of
diffuse alveolar damage (DAD) and a complete function recovery.
Recent murine models of ARDS due to H1N1 infection suggested
p63+/Krt5+ basal cells as tissue precursors for both airways and
alveoli, but no human confirmation have been provided to date.
Objectives: To investigate in human biopsy/autopsy samples of
ARDS if p63+/Krt5+ cells have a pivotal role in lung regeneration
following DAD. Secondarily, we challenged other possible markers
of human lung regenerative process activation. Methods: We
immunohistochemically analyzed a series of stem-cell related
markers in 15 lung specimens of patients with ARDS/diffuse
alveolar damage (DAD), comparing them with normal lung
samples. Measurements and Main Results: Bronchiolar
proliferation was not observed in regenerating parenchyma, where
hyperplastic type-II pneumocytes did not express basal-cell
markers Krt5 and ∆N-p63 (only scattered pneumocytes exhibited
TA-p63 immunoreactivity revealed by a pan-p63 antibody). A
striking finding in our study was a diffuse high percentage of
Krt14+ pneumocytes in all DAD cases, at variance with normal
controls where Krt14 expression was entirely negative. Variable
Krt14 expression was evidenced in bronchiolar epithelium. A high
proliferating index was observed in Krt14-expressing
pneumocytes on double-stain Ki67/Krt14 preparations. No
correlation was found between Krt14+ cells and clinical outcome
(p>1.00). Conclusions: Our study suggests that basal cells are not
involved in alveolar epithelial regeneration/repair and that Krt14
might be considered as a marker of alveolar regeneration/repair.